Renata PLC RENATA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 37.68
- Price/Sales
- 2.39
- Dividend Yield (Trailing)
- 0.82%
- Dividend Yield (Forward)
- 0.82%
- Total Yield
- 0.82%
Company Profile
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,079
- Website
- https://www.renata-ltd.com
Comparables
Valuation
|
Metric
|
RENATA
|
ACMELAB
|
002393
|
|---|---|---|---|
Price/Earnings (Normalized) | 37.68 | 6.60 | 29.64 |
Price/Book Value | 2.68 | 0.64 | 0.98 |
Price/Sales | 2.39 | 0.55 | 4.09 |
Price/Cash Flow | 34.07 | — | 21.69 |
Price/Earnings
RENATA
ACMELAB
002393
Financial Strength
|
Metric
|
RENATA
|
ACMELAB
|
002393
|
|---|---|---|---|
Quick Ratio | 0.34 | 0.25 | 3.22 |
Current Ratio | 1.29 | 1.13 | 3.73 |
Interest Coverage | 4.01 | 2.78 | 250.56 |
Quick Ratio
RENATA
ACMELAB
002393
Profitability
|
Metric
|
RENATA
|
ACMELAB
|
002393
|
|---|---|---|---|
Return on Assets (Normalized) | 4.51% | 4.83% | 2.91% |
Return on Equity (Normalized) | 7.29% | 10.22% | 3.50% |
Return on Invested Capital (Normalized) | 6.56% | 8.63% | 2.66% |
Return on Assets
RENATA
ACMELAB
002393
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wpnrdkwb | Cfdg | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Zqbjvflhpr | Rxkpsc | $71.9 Bil | |
HLN
| Haleon PLC ADR | Lzqccpvp | Ftxq | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Lybfqhg | Bwtv | $15.6 Bil | |
VTRS
| Viatris Inc | Frgxpsj | Hsq | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lpjkvtqk | Pccjh | $12.5 Bil | |
CTLT
| Catalent Inc | Nxlcdzh | Xqdsms | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Vcjspcyqk | Sdg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Xycvwprq | Tbj | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Stfzmjtw | Dvygzx | $3.5 Bil |